No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: The Alpha Omega Trial

Author(s):
Hoogeveen, E.K.; Geleijnse, J.M.; Kromhout, D.; van't Sant, P.; Gemen, E.F.; Kusters, R.; Giltay, E.J.
Published
2015
Publication type
Article / Letter to editor
n-3 Polyunsaturated fatty acidsalpha-linolenic acideicosapentaenoic aciddocosahexaenoic acidNT-proBNPrandomized double-blind placebo-controlled trial
Date issued
2015-05-31
Language
English
Is part of
European Journal of Preventive Cardiology (2015), Vol. 22, no. 5, p. 648-655
hdl
1887/102963
doi
10.1177/2047487314536694